$ONTO

ONTO INNOVATION INC. (ONTO): Completion of Acquisition or Disposition of Assets

ONTO INNOVATION INC. (ONTO) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 Onto Innovation Completes Strategic Investment in Rigaku Holdings Corporation Investment deepens strategic collaboration to advance next-generation X-ray-based process control solutions for semiconductor manufacturing Wilmington, Mass ., August 10, 2026 – Onto Innova

Original reporting
Published Aug 10, 2026, 12:16 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 12:39 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMergers & acquisitions
Primary signal
$ONTO
Bullish
medium confidence
Mentioned
$ONTO
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ONTOBullishMed
01

Why it matters

The key new information is the completion of the acquisition on Aug 10, 2026 (Tokyo time), confirming the transaction is no longer pending and is now moving into integration and benefit-realization phases.

02

Market read

Deal-close confirmation for a $720 million stake purchase can drive short-term repricing around execution risk and funding expectations.

03

What to watch

Traders may need to check ONTO’s financing structure and any post-close integration milestones, since this filing mainly confirms completion and price.

Relevance 7/10Novelty 8/10Timing: deal closed and disclosed via 8-K on Aug 10, 2026

Background

ONTO previously announced a Share Purchase Agreement (dated April 21, 2026) to acquire a 27% stake in Rigaku for about $720 million.

Company-level read

Ticker impact

$ONTOBullishMedium confidence
Context

ONTO completed its previously announced acquisition of 61,123,436 Rigaku shares, buying 27% for about $720 million.

Expected impact

Likely modest positive bias on deal-close confirmation, with follow-through dependent on how ONTO funds the $720 million and any updated integration/synergy expectations.

Evidence & confidence

The filing confirms deal completion and the purchase price, but provides no incremental guidance or financing terms beyond what was previously disclosed.

Market effects

Reinforces consolidation/strategic partnership momentum in metrology and process control/X-ray-related instrumentation, potentially affecting competitive positioning.

Limited direct regional read-through; transaction is cross-border (Rigaku) but disclosed by ONTO in the US.

Could modestly influence global semiconductor process control supply chain expectations if integration improves product roadmap and customer coverage.

Counterpoint

Deal-close headlines can fade if investors focus on dilution, leverage, or integration execution risk that is not detailed in this 8-K.

Key entities

  • ONTO

    Onto Innovation Inc., acquirer of a 27% stake in Rigaku, disclosed completion via SEC Form 8-K.

  • Rigaku Holdings Corporation

    Japanese company whose shares were acquired by ONTO; transaction represents 27% of issued and outstanding shares.

  • Atom Investment, L.P.

    Seller affiliate of The Carlyle Group under the Share Purchase Agreement.

  • The Carlyle Group

    Referenced as the parent of the seller affiliate (Atom Investment, L.P.).

Related articles

$ONTOHighAI 9/10

Onto Innovation (ONTO) Bets $720M on X-Ray Chip Technology

Onto Innovation (ONTO) acquired a 27% stake in Rigaku Holdings for $720M, expanding its X-ray chip tech collaboration. Q2 2026 revenue rose 35.3% YoY to $343.1M, beating guidance. Backlog exceeded $1B. Q3 guidance: $380M-$400M revenue, EPS $2.18-$2.38. H1 2026 net income fell to $93.9M from $98M YoY, with margins declining.

$LUNRMed

Stocks making the biggest moves midday: EyePoint, Intuitive Machines, Workday, JetBlue & more

Midday movers included Intuitive Machines, up about 9% after saying it received an authorization to proceed for a $600 million multisatellite communications program. EyePoint Pharmaceuticals fell about 70% after its Phase 3 wet AMD treatment failed its primary goal. JetBlue dropped 6% after a Seaport Research downgrade. Onto Innovation rose on Goldman coverage. Workday fell after a Deutsche Bank downgrade. Memory chip stocks rose after comments on Apple buying Chinese chips.

$ONTOMed

Onto Innovation Q2 Earnings Call Highlights

Onto Innovation (NYSE:ONTO) reported Q2 operating cash flow of $62 million and cash and short-term investments of about $1.9 billion as of June 30. In May it completed a $1.5 billion 0% convertible debt offering due 2031, netting about $1.2 billion, and used part for repurchases. Q3 revenue guidance is $380-$400 million; non-GAAP EPS about $2.28 at midpoint. Advanced-node revenue expected to grow over 35% in 2026; advanced-packaging growth outlook raised to about 80% for 2026.

$ONTOHigh

ONTO INNOVATION INC. (ONTO): Results of Operations and Financial Condition

ONTO INNOVATION INC. (ONTO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Onto Innovation Reports 2026 Second Quarter Results Wilmington, Mass ., August 6, 2026 – Onto Innovation Inc. (NYSE: ONTO) (“Onto Innovation,” “Onto,” or the “Company”) today announced financial results for the second quarter of 2026. Second Quarter Business and Financial Highlig

$AMATMedAI 8/10

These 5 Chip Stocks Are Riding the AI Fab Spending Wave

The article highlights AI-driven semiconductor capex and profiles five equipment/testing stocks. Applied Materials (AMAT) raised its 2026 semiconductor equipment growth forecast to over 30%. Onto Innovation (ONTO) reported Q1 revenue of $291.95M and a $240M+ HBM purchase agreement through 2027. It also cites record results for Lam Research (LRCX), KLA (KLAC), and Teradyne (TER).

$ONTOMedAI 8/10

Top 5 Stocks That Will Ride the Data Center Chip Equipment Supercycle

The article argues that AI-driven data center demand is boosting semiconductor capital equipment sales, citing strong YTD gains and results for Applied Materials, Lam Research, KLA, ASML, and Onto Innovation. It highlights Applied’s Q2 FY2026 revenue of $7.91B and raised 2026 equipment outlook to >30%, Lam’s March-quarter $5.84B revenue and $1.47 non-GAAP EPS, KLA’s $3.42B revenue and $9.40 EPS, ASML’s Q1 2026 $10.34B revenue and raised outlook to €36B–€40B, and Onto’s record Q4 2025 $266.87M re